Mustang Bio Inc [NASDAQ: MBIO] surged by $0.02 during the normal trading session on while it closed the day at $0.31.
Mustang Bio Inc stock has also gained 1.85% of its value over the past 7 days. However, MBIO stock has declined by -6.00% in the 3 months of the year. Over the past six months meanwhile, it has gained 18.61% and lost -77.15% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for MBIO stock reached $11.49 million, with 37.23 million shares outstanding and 33.65 million shares in the current float. Compared to the average trading volume of 1.75M shares, MBIO reached a trading volume of 4988932 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Mustang Bio Inc [MBIO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MBIO shares is $10.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MBIO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Mustang Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 18, 2021. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on October 02, 2020, representing the official price target for Mustang Bio Inc stock. Previously, the target price had yet another raise to $7, while Cantor Fitzgerald analysts kept a Overweight rating on MBIO stock.
MBIO stock trade performance evaluation
Mustang Bio Inc [MBIO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.85. With this latest performance, MBIO shares gained by 36.44% in over the last four-week period, additionally plugging by 18.61% over the last 6 months – not to mention a drop of -78.87% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MBIO stock in for the last two-week period is set at 64.97, with the RSI for the last a single of trading hit 71.47, and the three-weeks RSI is set at 59.29 for Mustang Bio Inc [MBIO]. The present Moving Average for the last 50 days of trading for this stock 0.2630, while it was recorded at 0.2969 for the last single week of trading, and 0.5730 for the last 200 days.
Mustang Bio Inc [MBIO]: An insightful look at the core fundamentals
Mustang Bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.46 and a Current Ratio set at 0.46.
Mustang Bio Inc [MBIO]: Institutional Ownership
There are presently around $2.31%, or 2.50%% of MBIO stock, in the hands of institutional investors.
